Financial results07.08.2020 at 07:50The GAAP loss for 6 months of 2020 was $64,199 million, up 34.8% from $47,623 million in the previous year. Revenues increased by 35.4% to $29,179 million compared to $21,551 million a year earlier.Intellia TherapeuticsNTLA20.58 USD+5.43%ReviewSource: ir.intelliatx.com